MS660P1
p170/p-Glycoprotein/MDR Ab-2 Mouse Monoclonal Antibody, Epredia™
Manufacturer: Fischer Scientific
Select a Size
| Pack Size | SKU | Availability | Price |
|---|---|---|---|
| Each of 1 | MS660P1-Each-of-1 | In Stock | ₹ 65,453.40 |
MS660P1 - Each of 1
In Stock
Quantity
1
Base Price: ₹ 65,453.40
GST (18%): ₹ 11,781.612
Total Price: ₹ 77,235.012
Antigen
p170/p-Glycoprotein/MDR Ab-2
Classification
Monoclonal
Concentration
200μg/mL
Host Species
Mouse
Quantity
500 μL
Research Discipline
Cancer and Tumor Biology
Target Species
Hamster, Human
Isotype
IgG1
Applications
Immunofluorescence, Western Blot
Clone
F4
Conjugate
Unconjugated
Immunogen
Human and hamster drug-resistant viable cells followed by crude plasma membranes
Regulatory Status
RUO
Primary or Secondary
Primary
Form
Concentrated
Related Products
Description
- Multi-drug resistance(MDR) associated p-glycoprotein (p170) causes resistance to various drugs in a number of cancer patients
- It exists in a soluble and membrane associated form
- Soluble P-glycoprotein is detected in extracellular fluids of cancer patients, such as malignant ascites and serum
- The Mr of soluble P-glycoprotein is the same as that of membrane bound P-glycoprotein
- Host Species: Mouse Clone: F4 Isotype: IgG1 Species Reactivity: Human, Chinese Hamster
- Does not react with mouse
- Others not known
- Epitope: Extracellular amino terminal half
- This epitope is resistant to formalin fixation and periodate oxidation and is different from those of other commonly known MAbs to p-glycoprotein, such as C219, JSB-1, and MRK16, which recognize an intracellular and extracellular epitope of p-glycoprotein, respectively
- Immunogen: Human and hamster drug-resistant viable cells followed by crude plasma membranes Molecular Weight: 170kDa Positive Control: Drug-resistant cells, Kidney or breast CA Cellular Localization: Membrane Recommended for: Immunohistochemistry (Formalin/paraffin) Western Blotting Immunofluorescence Flow Cytometry (Fixed cells only) Note: USA: RUO; Int'l: RUO
Compare Similar Items
Show Difference
Antigen: p170/p-Glycoprotein/MDR Ab-2
Classification: Monoclonal
Concentration: 200μg/mL
Host Species: Mouse
Quantity: 500 μL
Research Discipline: Cancer and Tumor Biology
Target Species: Hamster, Human
Isotype: IgG1
Applications: Immunofluorescence, Western Blot
Clone: F4
Conjugate: Unconjugated
Immunogen: Human and hamster drug-resistant viable cells followed by crude plasma membranes
Regulatory Status: RUO
Primary or Secondary: Primary
Form: Concentrated
Antigen:
p170/p-Glycoprotein/MDR Ab-2
Classification:
Monoclonal
Concentration:
200μg/mL
Host Species:
Mouse
Quantity:
500 μL
Research Discipline:
Cancer and Tumor Biology
Target Species:
Hamster, Human
Isotype:
IgG1
Applications:
Immunofluorescence, Western Blot
Clone:
F4
Conjugate:
Unconjugated
Immunogen:
Human and hamster drug-resistant viable cells followed by crude plasma membranes
Regulatory Status:
RUO
Primary or Secondary:
Primary
Form:
Concentrated
Antigen: p170/p-Glycoprotein/MDR Ab-2
Classification: Monoclonal
Concentration: 1mg/mL
Host Species: Mouse
Quantity: 100 μL
Research Discipline: Cancer and Tumor Biology
Target Species: Hamster, Human
Isotype: IgG1
Applications: Immunofluorescence, Western Blot
Clone: F4
Conjugate: Unconjugated
Immunogen: Human and hamster drug-resistant viable cells followed by crude plasma membranes
Regulatory Status: RUO
Primary or Secondary: Primary
Form: Concentrated
Antigen:
p170/p-Glycoprotein/MDR Ab-2
Classification:
Monoclonal
Concentration:
1mg/mL
Host Species:
Mouse
Quantity:
100 μL
Research Discipline:
Cancer and Tumor Biology
Target Species:
Hamster, Human
Isotype:
IgG1
Applications:
Immunofluorescence, Western Blot
Clone:
F4
Conjugate:
Unconjugated
Immunogen:
Human and hamster drug-resistant viable cells followed by crude plasma membranes
Regulatory Status:
RUO
Primary or Secondary:
Primary
Form:
Concentrated
Antigen: p170/p-Glycoprotein/MDR Ab-2
Classification: Monoclonal
Concentration: 1mg/mL
Host Species: Mouse
Quantity: 200 μL
Research Discipline: Cancer and Tumor Biology
Target Species: Hamster, Human
Isotype: IgG1
Applications: Immunofluorescence, Western Blot
Clone: F4
Conjugate: Unconjugated
Immunogen: Human and hamster drug-resistant viable cells followed by crude plasma membranes
Regulatory Status: RUO
Primary or Secondary: Primary
Form: Concentrated
Antigen:
p170/p-Glycoprotein/MDR Ab-2
Classification:
Monoclonal
Concentration:
1mg/mL
Host Species:
Mouse
Quantity:
200 μL
Research Discipline:
Cancer and Tumor Biology
Target Species:
Hamster, Human
Isotype:
IgG1
Applications:
Immunofluorescence, Western Blot
Clone:
F4
Conjugate:
Unconjugated
Immunogen:
Human and hamster drug-resistant viable cells followed by crude plasma membranes
Regulatory Status:
RUO
Primary or Secondary:
Primary
Form:
Concentrated
Antigen: LRP/MVP (Major Vault Protein) Ab-2
Classification: Monoclonal
Concentration: 200μg/mL
Host Species: Mouse
Quantity: 1 mL
Research Discipline: Cancer and Tumor Biology
Target Species: Human, Rat
Isotype: IgG2a κ
Applications: Immunohistochemistry (Paraffin), Immunoprecipitation, Western Blot
Clone: 1032
Conjugate: Biotin
Immunogen: Proteins precipitated with AER317 from the phosphocellulose column flow through of extract of human breast cancer MCF-7 cells
Regulatory Status: RUO
Primary or Secondary: Primary
Form: Concentrated
Antigen:
LRP/MVP (Major Vault Protein) Ab-2
Classification:
Monoclonal
Concentration:
200μg/mL
Host Species:
Mouse
Quantity:
1 mL
Research Discipline:
Cancer and Tumor Biology
Target Species:
Human, Rat
Isotype:
IgG2a κ
Applications:
Immunohistochemistry (Paraffin), Immunoprecipitation, Western Blot
Clone:
1032
Conjugate:
Biotin
Immunogen:
Proteins precipitated with AER317 from the phosphocellulose column flow through of extract of human breast cancer MCF-7 cells
Regulatory Status:
RUO
Primary or Secondary:
Primary
Form:
Concentrated